BioCryst Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of BCRX for the last quarter is 93.40 M USD, and it's 7.68% higher compared to the previous quarter. The net income of Q4 23 is -61.73 M USD.